- Home
- CDNA vs REPX Comparison
CDNA vs REPX Comparison
Compare CDNA & REPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- REPX
- Stock Information
- Founded
- CDNA 1998
- REPX 2016
- Country
- CDNA United States
- REPX United States
- Employees
- CDNA N/A
- REPX N/A
- Industry
- CDNA Medical Specialities
- REPX Oil & Gas Production
- Sector
- CDNA Health Care
- REPX Energy
- Exchange
- CDNA Nasdaq
- REPX Nasdaq
- Market Cap
- CDNA 712.2M
- REPX 581.0M
- IPO Year
- CDNA 2014
- REPX N/A
- Fundamental
- Price
- CDNA $14.45
- REPX $27.57
- Analyst Decision
- CDNA Buy
- REPX Strong Buy
- Analyst Count
- CDNA 8
- REPX 1
- Target Price
- CDNA $26.86
- REPX $47.00
- AVG Volume (30 Days)
- CDNA 1.3M
- REPX 120.2K
- Earning Date
- CDNA 11-03-2025
- REPX 11-05-2025
- Dividend Yield
- CDNA N/A
- REPX 5.77%
- EPS Growth
- CDNA N/A
- REPX N/A
- EPS
- CDNA 1.00
- REPX 4.52
- Revenue
- CDNA $340,826,000.00
- REPX $392,885,000.00
- Revenue This Year
- CDNA $12.73
- REPX N/A
- Revenue Next Year
- CDNA $11.90
- REPX $8.97
- P/E Ratio
- CDNA $14.57
- REPX $5.83
- Revenue Growth
- CDNA 14.72
- REPX N/A
- 52 Week Low
- CDNA $10.96
- REPX $21.98
- 52 Week High
- CDNA $31.52
- REPX $37.55
- Technical
- Relative Strength Index (RSI)
- CDNA 50.12
- REPX 49.55
- Support Level
- CDNA $13.95
- REPX $26.34
- Resistance Level
- CDNA $15.50
- REPX $27.92
- Average True Range (ATR)
- CDNA 0.55
- REPX 0.99
- MACD
- CDNA -0.10
- REPX 0.00
- Stochastic Oscillator
- CDNA 32.26
- REPX 42.59
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About REPX Riley Exploration Permian Inc.
Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations are in Kansas Properties and Tennessee Properties, among others.